CD274 and breast carcinoma: Especially, in a very recently published paper, Tao Qin’s work have revealed that patients with positive PD-L1 expression had significantly decreased survival compared to those with PD-L1 negative expression regardless of breast cancer subtype (Qin et al. 2015).